BioSpace News Archive

Alladapt Immunotherapeutics Inc. today announced that Ashley Dombkowski, Chief Executive Officer of Alladapt, will present a corporate overview at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 7:30 a.m. PT in San Francisco, CA.

Kymera Therapeutics, Inc. today announced the appointment of Ellen Chiniara, J.D., as Chief Legal Officer and Corporate Secretary.

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 10, 2023, at 6:00 p.m. ET.

Voyager Therapeutics, Inc. today announced that CEO Alfred W. Sandrock, Jr., M.D., Ph.D., will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023, at 10:30 a.m. PT / 1:30 p.m. ET.

Arbor Biotechnologies will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 1:30 p.m. PT.

Aravive, Inc. today announced the achievement of full enrollment in the registrational Phase 3 trial of batiraxcept plus paclitaxel for platinum-resistant ovarian cancer (PROC).

Lucira Health, Inc. announced the Canadian launch of Lucira Connect, a new virtual care program that allows Lucira test users the ability to test, learn about treatment options, access a telehealth consultation, and if appropriate, receive a prescription all from home for only the price of the test, excluding prescription costs.

Nurix Therapeutics, Inc. today announced that Arthur T. Sands, M.D., Ph.D., president and chief executive officer of Nurix, will present an overview of Nurix’s achievements in 2022 and major goals for 2023 at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023.

Axogen, Inc. today announced that Karen Zaderej, chairman, CEO, and president, will present at the JP Morgan 41st Annual Healthcare Conference in San Francisco.

Tonix Pharmaceuticals Holding Corp. today announced the appointment of Zeil Rosenberg, M.D., M.P.H. as its new Executive Vice President, Medical.